Cue Biopharma Inc (CUE)
1.50
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 16:00
1.57
+0.07
(+4.67%)
After-Hours: 20:00
Cue Biopharma Total Return Level: 1.50 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 1.50 |
November 13, 2024 | 1.50 |
November 12, 2024 | 1.70 |
November 11, 2024 | 1.87 |
November 08, 2024 | 1.72 |
November 07, 2024 | 1.78 |
November 06, 2024 | 1.65 |
November 05, 2024 | 1.71 |
November 04, 2024 | 1.49 |
November 01, 2024 | 1.52 |
October 31, 2024 | 1.61 |
October 30, 2024 | 1.75 |
October 29, 2024 | 1.69 |
October 28, 2024 | 1.78 |
October 25, 2024 | 1.48 |
October 24, 2024 | 1.56 |
October 23, 2024 | 1.57 |
October 22, 2024 | 1.60 |
October 21, 2024 | 1.68 |
October 18, 2024 | 1.21 |
October 17, 2024 | 1.11 |
October 16, 2024 | 1.07 |
October 15, 2024 | 1.12 |
October 14, 2024 | 1.21 |
October 11, 2024 | 1.23 |
Date | Value |
---|---|
October 10, 2024 | 1.33 |
October 09, 2024 | 1.205 |
October 08, 2024 | 1.23 |
October 07, 2024 | 1.385 |
October 04, 2024 | 1.16 |
October 03, 2024 | 0.8192 |
October 02, 2024 | 0.7334 |
October 01, 2024 | 0.7197 |
September 30, 2024 | 0.7572 |
September 27, 2024 | 0.6794 |
September 26, 2024 | 0.4541 |
September 25, 2024 | 0.4751 |
September 24, 2024 | 0.4847 |
September 23, 2024 | 0.4792 |
September 20, 2024 | 0.524 |
September 19, 2024 | 0.565 |
September 18, 2024 | 0.5537 |
September 17, 2024 | 0.57 |
September 16, 2024 | 0.5634 |
September 13, 2024 | 0.589 |
September 12, 2024 | 0.58 |
September 11, 2024 | 0.5894 |
September 10, 2024 | 0.569 |
September 09, 2024 | 0.569 |
September 06, 2024 | 0.59 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.4541
Minimum
Sep 26 2024
30.73
Maximum
Jun 02 2020
8.283
Average
4.382
Median
Total Return Level Benchmarks
Biomarin Pharmaceutical Inc | 65.60 |
Arbutus Biopharma Corp | 3.63 |
GlycoMimetics Inc | 0.3994 |
FibroGen Inc | 0.3699 |
Cidara Therapeutics Inc | 14.48 |